Environmental factors such as chemical pollutants, psychosocial stressors, and antibiotics as well as an unhealthy diet affect the human immune system and microbiome. They can contribute to an increased risk of infection, reduced immune resilience, and an altered immune response to vaccination. To date, there has been little research into how these factors affect viral immune responses in pregnant women as well as in children and adolescents. The aim of the EMVIC collaborative project is to close this gap using data from the LiNA mother–child cohort of the Helmholtz Centre for Environmental Research (UFZ). The project is coordinated by the UFZ with participation from the University of Leipzig, Hannover Medical School, and the Helmholtz Centre for Infection Research (HZI), and will start on 1 July.

There is an urgent need for novel drugs in the fight against infectious diseases, and natural compounds derived from soil bacteria are a promising source for their development. Researchers at HIPS, the HZI site in Saarland, are counting on the public’s help: The citizen science project MICROBELIX aims to harness the biodiversity of soil bacteria for drug discovery.

The Friends of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Technische Universität Braunschweig have awarded Prof. Dr. Craig M. Crews (Yale University, USA) the 2026 Inhoffen Medal. Craig Crews is regarded as a pioneer of innovative therapeutic approaches. The Inhoffen Medal recognises outstanding scientific achievements in the field of organic chemistry and drug discovery. The award ceremony took place as part of the 31st Hans Herloff Inhoffen Lecture at the Haus der Wissenschaft in Braunschweig on 11 June 2026.